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Detecting Epidemic 
Malaria, Uganda
To the Editor: In the ﬁ  eld of ma-
laria epidemic early warning, there ex-
ists an unfortunate but frequently ac-
curate perception that health systems 
in many affected countries learn of 
epidemics by way of the popular press 
rather than through formal disease sur-
veillance systems. Malaria epidemics 
are often easily recognized (albeit too 
late) by laypersons (1), but most rou-
tine disease surveillance systems lack 
the ability to provide accurate, timely 
indications of aberrations in case num-
bers. The World Health Organization 
(WHO) has set speciﬁ  c  targets  for 
early detection and control of malaria 
epidemics as part of a wider strategy to 
cut the global impact of malaria in half 
by 2010 (2). We describe experiences 
during a recent epidemic in southwest 
Uganda and examine the performance 
of a pilot early detection system.
In 2002, the Ugandan Ministry of 
Health began developing and piloting 
a new district-level malaria monitor-
ing system in Kabale and Rukungiri 
(3). Located in Uganda’s southwest-
ern highlands, these districts have ex-
perienced several serious malaria epi-
demics in recent years, most notably 
during the El Niño year of 1998 (4,5). 
In this new system, data generated 
from representative health facilities 
are collated, entered on computer, and 
analyzed by district teams on a weekly 
basis. Incoming data on clinical ma-
laria are compared with a baseline of 
historical illness data from which the 
effects of long-term temporal trends 
have been removed, and an objective 
anomaly measure, or “standardized 
departure,” is used to provide a simple, 
intuitive index of deviation from ex-
pected weekly levels of incidence (3). 
Electronic reports are disseminated by 
email to the National Malaria Control 
Programme (NMCP) and others, in-
cluding WHO and the United Nations 
Children’s Fund.
The monitoring system detected 
2 malaria outbreaks in Kabale, 1 each 
in 2005 and 2006. During the most re-
cent outbreak, the ﬁ  rst warnings of ab-
normally high malaria incidence were 
communicated from the district team 
to the NMCP on June 5, 1 month be-
fore reports of the outbreak appeared 
in the press and >2 weeks before case 
numbers began to peak (Figure, panel 
A). In the 6 weeks from May 29 to 
July 9, Kabale’s 5 sentinel sites re-
corded 4,637 clinical malaria cases, 
159% more than expected for this pe-
riod. Although the sentinel network 
consists of health centers with limited 
inpatient facilities, available data on 
admissions showed a similar tempo-
ral pattern, with 616 patients admitted 
during the same 6-week period, 188% 
more than expected.
Although the ability of the system 
to generate timely epidemic warnings 
is encouraging, data from 1 sentinel 
site highlighted a potential limita-
tion of using routine data from clini-
cal diagnoses of malaria as a basis for 
epidemic detection. As elsewhere, 
routine outpatient data for Bufundi 
Health Centre suggested the occur-
rence of a malaria outbreak starting in 
early June and peaking in early July 
of 2006 (Figure, panel B). The slight 
delay in the onset of the outbreak at 
this site was plausible, given its high 
elevation (2,200 m) and geographic 
remoteness. Data for patients with 
parasitologically conﬁ  rmed  malaria, 
available through an ongoing malaria 
transmission study at Bufundi Health 
Centre (3), showed a different tempo-
ral pattern of incidence, however. As 
Figure. A) Weekly observed and expected numbers of outpatient (OP) and inpatient 
(IP) cases of clinically diagnosed malaria from sentinel health centers in Kabale district, 
southwestern Uganda, May–August 2006. B) Weekly numbers of clinically diagnosed 
malaria cases and the proportion of case-patients subsequently testing positive for 
Plasmodium falciparum infection by rapid diagnostic test at Bufundi, Kabale district, 
southwestern Uganda, May–August 2006.LETTERS
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part of this study, all samples from ma-
laria case-patients identiﬁ  ed  through 
clinical diagnosis were subject to a 
Paracheck-Pf immunoassay test (Or-
chid Biomedical Systems, Verna, Goa, 
India). Results indicated that, at the 
peak of the apparent malaria outbreak, 
the percentage of samples from clini-
cally diagnosed cases that produced a 
positive diagnostic test was as low as 
4% (Figure, panel B). These results 
are unlikely to reﬂ  ect poor diagnostic 
performance of the testing (6); febrile 
illness other than malaria was likely 
the cause of the outbreak.
Recent experiences in Kabale 
also highlight the potentially unwieldy 
nature of indoor residual spraying 
campaigns in the absence of spatial 
targeting. In Kabale, a district-wide 
spraying campaign supported by the 
US President’s Malaria Initiative (7) 
was planned for the 2006 transmission 
season. However, shortages of trained 
personnel and other institutional de-
lays meant that spraying could not 
begin until the third week of June, by 
which time the epidemic had peaked 
(and densities of vector mosquitoes 
had presumably begun to fall). By 
July 17, <50% of the targeted struc-
tures had been sprayed. In the future, 
careful targeting of spraying to areas 
of highest epidemic risk might lead to 
more timely completion of spraying 
activities. It might also be beneﬁ  cial 
to create special spray teams that can 
respond quickly to speciﬁ  c alerts.
Recent experiences in Kabale 
have underlined the potential value 
of simple monitoring tools for early 
detection of epidemics but have also 
shown potential barriers to effective 
epidemic control. Our ﬁ  ndings high-
light the need to build systems that 
improve routine collection of data 
on parasitologically conﬁ  rmed  cases 
of malaria and allow rapid investiga-
tion of anomalies in incoming clinical 
data. It is equally important to develop 
procedures that translate early warn-
ing information into timely decisions 
concerning which epidemic control 
measures to use and how best to target 
them (8). Without these procedures, 
the value of early detection will be     
seriously undermined.
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Extensively 
Drug-resistant 
Tuberculosis, Italy 
and Germany 
To the Editor: Twenty-three 
countries have reported >1 case of 
extensively drug-resistant tubercu-
losis (XDR TB) (1); however, in-
formation about XDR TB is still in-
complete. In particular, the response 
of XDR TB to treatment in countries 
with low incidence is not known. We 
compared mortality rates from XDR 
TB with those from multidrug-resis-
tant (MDR) TB.
We analyzed data from all cul-
ture-conﬁ   rmed TB cases diagnosed 
during 2003–2006 by the TB clinical 
reference centers in Italy (Sondalo, 
Milan, Rome) and Germany (Borstel, 
Grosshansdorf, Bad-Lippspringe) and 
reviewed original clinical records. 
Drug susceptibility testing for ﬁ  rst- 
and second-line anti-TB drugs was 
performed according to World Health 
Organization (WHO) recommenda-
tions by quality-assured  laboratories 
and retested at WHO Supranational 
Reference Laboratories (Rome/Milan; 
Borstel) (2–4).
XDR TB was deﬁ   ned as resis-
tance to at least rifampin and isoniazid 
(MDR TB deﬁ   nition) in addition to 